Related Experiment Videos
An in vitro fibroblast model system to study myc-driven tumour progression
1Leukemia Research and Viral Pathology Unit, Children's Medical Research Foundation, Sydney, NSW, Australia.
International Journal of Cancer
|April 22, 1992
Summary
Deregulated myc gene expression drives tumor progression and increases cell transformation and tumorigenicity. Higher myc levels correlate with greater tumor potential and metastatic capacity, indicating myc
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The myc oncogene family plays a critical role in cell proliferation, differentiation, and apoptosis.
- Understanding myc's role in tumor progression is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role of deregulated myc gene expression in fibroblast cell transformation and tumor progression.
- To determine the correlation between myc expression levels and cellular transformation and tumorigenic potential.
Main Methods:
- Introduction of exogenous human c-myc and avian v-myc genes into Rat-1 and Rat-1 (PT) fibroblast cell lines via transfection and retroviral infection.
- Assessment of transformation and tumorigenicity in vitro and in vivo.
- Correlation analysis between myc expression levels and phenotypic characteristics.
Main Results:
- Introduction of exogenous myc genes increased transformation and tumorigenicity in both cell lines.
- Myc expression levels directly correlated with the degree of transformation and tumorigenic potential.
- Tumor progression parameters were enhanced by in vitro and in vivo passaging, suggesting additional contributing factors.
Conclusions:
- Deregulated myc gene expression is a key driver of tumor progression.
- Transformation and tumorigenicity are directly proportional to the level of exogenous myc expression.
- Myc expression may enhance cellular metastatic capacity, highlighting its multifaceted role in cancer.